Chapter 19
Myocardial Protection with Beta-Blockers in Valvular Surgery
Nawwar Al Attar FRCS, MSc, FETCS,
Marcio Scorsin MD, PhD,
Arrigo Lessana MD, FETCS,
Nawwar Al Attar FRCS, MSc, FETCS
Search for more papers by this authorMarcio Scorsin MD, PhD
Search for more papers by this authorArrigo Lessana MD, FETCS
Search for more papers by this authorNawwar Al Attar FRCS, MSc, FETCS,
Marcio Scorsin MD, PhD,
Arrigo Lessana MD, FETCS,
Nawwar Al Attar FRCS, MSc, FETCS
Search for more papers by this authorMarcio Scorsin MD, PhD
Search for more papers by this authorArrigo Lessana MD, FETCS
Search for more papers by this authorBook Editor(s):Tomas A. Salerno MD,
Marco Ricci MD,
Tomas A. Salerno MD
Professor and Chief, Division of Cardiothoracic Surgery, University of Miami, Jackson Memorial Hospital, Miami, Florida
Search for more papers by this authorMarco Ricci MD
Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Staff Surgeon, Section of Pediatric Cardiac Surgery, University of Miami, Jackson Memorial Hospital, Miami, Florida
Search for more papers by this authorFirst published: 13 November 2003
Summary
This chapter contains sections titled:
-
Introduction
-
Pathophysiology of valvular diseases and implications on myocardial protection
-
Esmolol as an innovative agent in warm blood cardioplegia
-
Cardioplegia protocol
-
Results
-
Discussion
-
Conclusions
-
Acknowledgments
References
- Salerno TA, Houck JP, Barrozo CAM et al. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg 1991; 51: 245–7.
- Salerno TA, Wasan SM, Charrette EJ. Glucose substrate in myocardial protection. J Thorac Cardiovasc Surg 1980; 79: 59–62.
- Menasche P, Piwnica A. Free radicals and myocardial protection: a surgical viewpoint. Ann Thorac Surg 1989; 47: 939–45.
- Gurevitch J, Pevni D, Frolkis I et al. Captopril in cardio-plegia and reperfusion: protective effects on the ischemic heart. Ann Thorac Surg 1997; 63: 627–33.
- Noera G. When and why CPD in continuous warm blood cardioplegia? Ann Thorac Surg 1993; 56: 1217–18.
- Katayama O, Ledingham SJM, Amrani M et al. Functional and metabolic effect of adenosine in cardio-plegia and reperfusion: protective effects on the ischemic heart. Ann Thorac Surg 1997; 63: 449–55.
- Wechsler AS, Abd-Elfattah A. Future cardioprotective considerations. J Card Surg 1993; 8: 492–502.
- Yasuda T, Kamiya H, Tanaka Y et al. Ultra-short-acting beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur J Cardiothorac Surg 2001; 19: 647–52.
- Sharma SK, Kini A, Marmur JD et al. Cardioprotective effect of prior beta-blocker therapy in reducing creatinine kinase-MB elevation after coronary intervention. Benefit is extended to improvement in intermediate-term survival. Circulation 2000; 102: 166–72.
- Griggs DM, Chen CC, Tchokoev VV. Subendocardial anaerobic metabolism in experimental aortic stenosis. Am J Physiol 1973; 224: 607–12.
- Eberli FR, Ritter M, Schwitter J et al. Coronary reserve in patients with aortic valve disease before and after successful aortic valve replacement. Eur Heart J 1991; 12: 127–38.
- Marcus ML, Koyanagi S, Harrison DG et al. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med 1983; 75: 62–6.
- Griggs DM Jr, Chen CC. Coronary hemodynamics and regional myocardial metabolism in experimental aortic insufficiency. J Clin Invest 1974; 53: 1599–606.
- Carabello BA. Timing of surgery in mitral and aortic stenosis. Cardiol Clin 1991; 9: 229–38.
- Kennedy JW, Yarnall SR, Murray JA et al. Quantitative angiocardiography: relationships of left atrial and ventricular pressure and volume in mitral valve disease. Circulation 1970; 41: 817–24.
- Choi BW, Bacharach SL, Barcour DJ et al. Left ventricular systolic dysfunction: diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. Am J Cardiol 1995; 75: 526–9.
- Bolen JL, Lopes MG, Harrison DC et al. Analysis of left ventricular function in response to afterload changes in patients with mitral stenosis. Circulation 1975; 52: 894–900.
- Schofield PM. Invasive investigation of the mitral valve. In: FC Wells, LM Shapiro, eds. Mitral Valve Disease. Oxford: Butterworth-Heineman, 1996: 84.
- Schwartz R, Myerson RM, Lawrence LT et al. Mitral stenosis, massive pulmonary hemorrhage, and emergency valve replacement. N Engl J Med 1966; 275: 755–8.
- Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J 1992; 123: 1610–32.
- Diker E, Aydogdu S, Ozdemir M et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996; 77: 96–8.
- Fenster MS, Feldman MD. Mitral regurgitation: an overview. Curr Probl Cardiol 1995; 20: 193–280.
- Brauwald E. Mitral regurgitation: physiologic, clinical and surgical considerations. N Engl J Med 1969; 281: 425–33.
- Carabello BA. The pathophysiology of mitral regurgita-tion. J Heart Valve Dis 2000; 9: 600–8.
- Ross J Jr. Adaptations of the left ventricle to chronic volume overload. Circ Res 1974; 34/35 (Suppl II:): 64–70.
- Spinale FG, Ishihra K, Zile M et al. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. J Thorac Cardiovasc Surg 1993; 106: 1147–57.
- Yun KL, Rayhill SC, Niczyporuk MA et al. Left ventricular mechanics and energetics in the dilated canine heart: acute versus chronic mitral regurgitation. J Thorac Cardiovasc Surg 1992; 104: 26–39.
- Yun KL, Rayhill SC, Niczyporuk MA et al. Mitral valve replacement in dilated canine hearts with chronic mitral regurgitation. Circulation 1991; 84 (Suppl III): 112–24.
- Ede MYeJ, Gregorash L et al. Beyond hyperkalemia: beta-blockers-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg 1997; 63: 721–7.
- Lessana A, Pargaonkar S, Yu HQ et al. External stabilization of coronary sinus catheter. J Card Surg 1995; 10: 96–7.
-
Le Houerou D,
Singh AI,
Romano M et al.
Minimal hemodilution and optimal potassium use during nor-mothermic aerobic arrest.
Ann Thorac Surg
1992;
54:
809–16.
10.1016/0003-4975(92)91055-E Google Scholar
- Le Houreou D, Pargaonkar S, Lessana A. Cardioplegia delivery systems for warm cardioplegia. In: TA Salerno, eds. Warm Heart Surgery. London: Arnold, 1995: 50–2.
- Goodman J, Gilman J. Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1995: 238–89.
- Handy JR, Spinale FG, Mukherjee R et al. Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg 1994; 107: 1050–8.
- Sum CY, Yacobi A, Kartzinel R et al. Kinetics of esmolol, an ultra-short acting beta blocker, and of its major metabolites. Clin Pharmacol Ther 1983; 34: 427–34.
- Lamaeris TW, de Zeeuw S, Albert G et al. Time course and mechanism of myocardial catecholamines release during transient ischemia in vivo. Circulation 2000; 101: 2645–50.
- Thandroyen FT, Muntz KH, Buja LM et al. Alteration in beta-adrenergic receptors, adenlyate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion. Circulation 1990; 82: 30–7.
- Tevaearai HT, Walton GB, Eckhart AD, Keys JR, Koch WJ. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation. Eur J Cardiothorac Surg 2002; 22: 733–7.
- Hekmat K, Clemens RM, Mehlhorn U et al. Emergency coronary artery surgery after failed PTCA: myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood. Thorac Cardiovasc Surg 1998; 46: 333–8.
- Rescigno G, Nataf P, Raffoul R et al. Continuous warm blood cardioplegia pitfalls and solutions. Heart Surg Forum 1998; 1: 142–5.
- Chocron S, Kaili D, Yan Y et al. Intermediate lukewarm (20°C) antegrade intermittent blood cardioplegia compared with cold and warm blood cardioplegia. J Thorac Cardiovasc Surg 2000; 119: 610–16.
- Yasuda T, Kawasuji M, Sakakibara N et al. Ultrastructural assessment of the myocardium receiving intermittent antegrade warm blood cardioplegia. Cardiovasc Surg 1998; 6: 282–7.
- Bernhard WF, Schwarz HF, Malick NP. Intermittent cold coronary perfusion as an adjunct to open heart surgery. Surg Gynecol Obstet 1960; 111: 744–50.
- Buckberg GD, Brazier JR, Nelson R et al. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg 1977; 73: 87–94.
- Mehlhorn U, Allen SJ, Adams DL et al. Cardiac surgical conditions induced by beta-blockade: effect on myocar-dial fluid balance. Ann Thorac Surg 1996; 62: 143–50.
- Warters RD, Allen SJ, Davis KL et al. Beta-blockade as an alternative to cardioplegic arrest during cardiopul-monary bypass. Ann Thorac Surg 1998; 65: 961–6.
- Mehlhorn U, Fattah M, Kuhn-Regnier F et al. Impact of myocardial protection during coronary bypass surgery on patient outcome. Cardiovasc Surg 2001; 9: 482–6.
- Hattler BG, Oddis CV, Zeevi A et al. Regulation of constitutive nitric oxide synthase activity by the human heart. Am J Cardiol 1995; 76: 957–9.
- Mayers I, Hurst T, Puttagunta L et al. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg 2001; 122: 746–52.
